Liabilities / Assets
71st percentile
Tied with the lowest-debt nonprofits in its peer group.
990EZ • Fiscal year 2012 • EIN 20-2710571
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
71st percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
43rd percentile
Higher net margin than 43% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
3rd percentile
Faster asset growth than 3% of similar nonprofits.
Revenue Growth
4th percentile
Faster revenue growth than 4% of similar nonprofits.
Assets
Down$4,504
Down $20,628 (-82%) from 2011
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2011
Revenue
Down$37,498
Down $124,319 (-77%) from 2011
Expenses
Down$37,498
Down $149,885 (-80%) from 2011
Net Income
Up$0
Up $25,566 (+100%) from 2011
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The mission of the organization is to accelerate the discovery and development of applications of new therapies for disease and translate those therapies into treatments for patients through the science of regenerative medicine. The organization focuses on obtaining federal and other grant funds and working with other organizations developing regenerative medicine and products to accomplish its mission.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990EZSummary only. Only limited summary data is available for this year.